Testing effectiveness (Phase 2)Study completedNCT04388176What this trial is testingCold Challenge With C21 in RPWho this might be right forRaynaud PhenomenonSystemic Sclerosis Vicore Pharma AB 20
Testing effectiveness (Phase 2)Study completedNCT00480753What this trial is testingDose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's PhenomenonWho this might be right forRaynaud's Disease MediQuest Therapeutics 15
Post-approval studies (Phase 4)Study completedNCT00048776What this trial is testingSafety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's PhenomenonWho this might be right forRaynaud's Disease Otsuka America Pharmaceutical 75
Post-approval studies (Phase 4)Not Yet RecruitingNCT07112183What this trial is testingOpen Label Treprostinil Raynaud's StudyWho this might be right forRaynaud's DiseaseRaynaud PhenomenaRaynauds Brigham and Women's Hospital 30
Large-scale testing (Phase 3)UnknownNCT00577304What this trial is testingA Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's PhenomenonWho this might be right forRaynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Other Autoimmune Disease MediQuest Therapeutics 200
Testing effectiveness (Phase 2)Ended earlyNCT01315899What this trial is testingEfficacy of ORM-12741 for Prevention of Raynaud's PhenomenonWho this might be right forRaynaud's Phenomenon Orion Corporation, Orion Pharma 15
Testing effectiveness (Phase 2)Study completedNCT02260557What this trial is testingEffects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud's Phenomenon Secondary to Systemic Sclerosis Actelion 74
Large-scale testing (Phase 3)Study completedNCT03717961What this trial is testingEfficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud Phenomenon Secondary to Systemic Sclerosis Assistance Publique - Hôpitaux de Paris 91
Testing effectiveness (Phase 2)Study completedNCT02228850What this trial is testingStudy of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud's Phenomenon Secondary to Systemic Sclerosis NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) 35
Large-scale testing (Phase 3)Study completedNCT00266669What this trial is testingPhase III Study of Topical Gel for Treatment and Prevention of Raynaud's PhenomenonWho this might be right forRaynaud's Disease MediQuest Therapeutics 200
Large-scale testing (Phase 3)Study completedNCT00253331What this trial is testingLab Study of MQX-503 in Treatment of Raynaud'sWho this might be right forRaynaud DiseaseRaynaud Disease Secondary to SclerodermaRaynaud Secondary to Other Autoimmune Disease MediQuest Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT03867097What this trial is testingIntravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)Who this might be right forRaynaud Phenomenon Secondary to Systemic Sclerosis Civi Biopharma, Inc. 34
Very early researchStudy completedNCT03027674What this trial is testingTopical 10 % Nifedipine Versus 5% Sildenafil in Secondary RaynaudWho this might be right forRaynaud Phenomenon Due to TraumaRaynaud DiseaseSystem; Sclerosis+3 more Pontificia Universidad Catolica de Chile 10
Testing effectiveness (Phase 2)Study completedNCT01090492What this trial is testingPF-00489791 For The Treatment Of Raynaud'sWho this might be right forRaynaud's DiseasePeripheral Vascular Disease Pfizer 243
Large-scale testing (Phase 3)Study completedNCT04040322What this trial is testingIntravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)Who this might be right forRaynaud's Phenomenon Secondary to Systemic Sclerosis Civi Biopharma, Inc. 198
Testing effectiveness (Phase 2)Ended earlyNCT04915950What this trial is testingAssess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud's Phenomenon Secondary to Systemic Sclerosis Pfizer 13
Testing effectiveness (Phase 2)Study completedNCT00378521What this trial is testingDose Response Study of a Topical Gel for the Treatment of Raynaud's PhenomenonWho this might be right forRaynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Autoimmune Disease MediQuest Therapeutics 15
Not applicableStudy completedNCT00946738What this trial is testingThe Effect of Physical Therapy on Raynaud's Phenomenon Secondary to Systemic SclerosisWho this might be right forRaynaud's PhenomenonSystemic Sclerosis Charite University, Berlin, Germany 28
Testing effectiveness (Phase 2)Study completedNCT00707187What this trial is testingTrial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual DysfunctionWho this might be right forSystemic Sclerosis University of Medicine and Dentistry of New Jersey 120
Testing effectiveness (Phase 2)UnknownNCT02356809What this trial is testingSafety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's PhenomenonWho this might be right forSecondary Raynaud's Phenomenon Artgen Biotech 30